Vaccines in Taiwan are registered through the TFDA by submitting clinical trial data, manufacturing details, and evidence of Good Manufacturing Practice (GMP) compliance. The process includes assessments of safety, efficacy, and immunogenicity. Accelerated pathways may apply for urgent needs, such as pandemic vaccines, ensuring timely approval while maintaining quality standards.